Safeguarding Against Pneumocystis: Efficacy of TMP/SMX in Autoimmune Disease Management

by telrheum | May 19, 2024 | Autoimmune Diseases, Biologic Therapy, Pneumocystis Jirovecii

This systematic review and meta-analysis led by Athanasios Vassilopoulos and colleagues focuses on the effectiveness of prophylactic Trimethoprim-Sulfamethoxazole (TMP/SMX) in preventing Pneumocystis Jirovecii Pneumonia (PJP) among patients with Autoimmune...

Hepatitis B Reactivation with Rheumatoid Arthritis Treatment Choices

by telrheum | May 19, 2024 | Il-6 inhibitors, Hepatitis B, Infections, JAK Inhibitor

This study, presented at ACR Convergence 2023 by Akhil Sood, Janice Lin, and Neha Shah from Stanford University, examines the risk of Hepatitis B virus (HBV) reactivation in patients with rheumatoid arthritis (RA) who are being treated with either JAK inhibitors or...

Rituximab-Induced Immunoglobulin Deficiency: A Closer Look at Infection Outcomes

by telrheum | May 19, 2024 | Biologic Therapy, Infections, Lupus, Rheumatoid Arthritis, Rituximab, Vasculitis

The article “Risk of Severe Infections Associated with Immunoglobulin Deficiency Under Rituximab Therapy in Immune Mediated Inflammatory Diseases” by Claire Rempenault and colleagues evaluates the connection between severe infections and immunoglobulin deficiency in...

Chronic Intersection: Exploring Long Covid Effects in Arthritis Patients

by telrheum | May 10, 2024 | Autoimmune Diseases, Infections, Viral Infections

The article “Long Covid in Persons with Self-Reported Arthritis – Symptoms, Associated Factors and Functional Limitations” by Debbie Ehrmann Feldman and Barbara Mazer explores the impact of long Covid on individuals with arthritis. Presented at ACR...

Balancing Treatment and Risk: HBV Reactivation in RA Patients on JAK and IL-6 Inhibitors

by telrheum | Apr 23, 2024 | Biologic Therapy, Il-6 inhibitors, Infections, JAK Inhibitor

This article, “Risk of Hepatitis B Virus Reactivation in Patients with Rheumatoid Arthritis Receiving JAK Inhibitor or IL-6 Inhibitor: A Systematic Review and Meta-Analysis” by Akhil Sood, Janice Lin, and Neha Shah from Stanford University, presents a study that looks...

Rituximab Therapy and Infection Risk: Unveiling the Role of Immunoglobulin Deficiency

by telrheum | Apr 21, 2024 | Biologic Therapy, Immunoglobulins, Infections

The study titled “Risk of Severe Infections Associated with Immunoglobulin Deficiency Under Rituximab Therapy in Immune Mediated Inflammatory Diseases” conducted by Claire Rempenault and colleagues, explored the connection between severe infections and...